Araie M, Takase M, Sakai Y, Ishii Y, Yokoyama Y, Kitagawa M
Jpn J Ophthalmol. 1982;26(3):248-63.
The ocular penetration of two beta-adrenergic blockers, befunolol and timolol, was studied using albino and pigmented rabbits. A 1% ophthalmic solution of 14C-befunolol hydrochloride or 14C-timolol maleate was instilled in one eye of nonsedated rabbits, and the concentrations of radioactive material in the ocular tissues were determined at various intervals. In the albino rabbit, the time courses of the concentration changes in the cornea and aqueous humor could be analyzed on the basis of a compartment theory, and the following coefficients were calculated using a computer; i.e., permeability of the corneal epithelium (kep), the distribution volume in the anterior chamber (Va), the cornea-aqueous transfer coefficient in reference to the corneal volume (kc.ca), the aqueous-cornea transfer coefficient in reference to Va (ka.ac), the loss rate from the anterior chamber (ko) and the steady state distribution ratio between the aqueous and cornea (rac). The following values were obtained for befunolol: kep--2.6 x 10(-3) cm hr-1, kc.ca--0.51 hr-1, ka.ac--0.18 hr-1, ko--2.7 hr-1, Va--250 microliters and rac--0.9. Those of timolol were as follows: kep--2.3 x 10(-3) cm hr-1, kc . ca--0.82 hr-1 and ko--2.5 hr-1. The estimates for Va and rac could not be calculated from the data obtained in the timolol experiment. Assuming that Va and rac for befunolol were also applicable for timolol, ka.ac for timolol was calculated to be 0.25 to 0.29 hr-1. The beta-adrenergic blockers tested here penetrated the cornea rather easily and they were lost from the anterior chamber mainly by diffusion, probably into the blood circulation through the anterior uvea. The data obtained in the pigmented rabbit indicated that these beta-adrenergic blockers are bound to the melanin-containing ocular tissues and are released from there very slowly. It is suggested that in heavily pigmented subjects, beta-adrenergic blockers might be less effective after short-term use and, furthermore, intraocular binding may occur after long-term use.
使用白化兔和有色兔研究了两种β-肾上腺素能阻滞剂倍他洛尔和噻吗洛尔的眼内渗透情况。将1%的14C-盐酸倍他洛尔或14C-马来酸噻吗洛尔眼药水滴入未麻醉兔子的一只眼睛,并在不同时间间隔测定眼组织中放射性物质的浓度。在白化兔中,角膜和房水中浓度变化的时间进程可根据房室理论进行分析,并使用计算机计算以下系数;即角膜上皮的通透性(kep)、前房的分布容积(Va)、相对于角膜容积的角膜-房水转运系数(kc.ca)、相对于Va的房水-角膜转运系数(ka.ac)、前房的损失率(ko)以及房水与角膜之间的稳态分布比(rac)。倍他洛尔的以下值为:kep--2.6×10(-3) cm/hr,kc.ca--0.51/hr,ka.ac--0.18/hr,ko--2.7/hr,Va--250微升,rac--0.9。噻吗洛尔的如下:kep--2.3×10(-3) cm/hr,kc.ca--0.82/hr,ko--2.5/hr。Va和rac的估计值无法根据噻吗洛尔实验获得的数据计算得出。假设倍他洛尔的Va和rac也适用于噻吗洛尔,则噻吗洛尔的ka.ac计算为0.25至0.29/hr。此处测试的β-肾上腺素能阻滞剂相当容易穿透角膜,并且它们主要通过扩散从前房消失,可能是通过眼前葡萄膜进入血液循环。在有色兔中获得的数据表明,这些β-肾上腺素能阻滞剂与含黑色素的眼组织结合,并从那里非常缓慢地释放。有人提出,在色素沉着严重的受试者中,β-肾上腺素能阻滞剂在短期使用后可能效果较差,此外,长期使用后可能会发生眼内结合。